PharmaCrisis

$TRUMP THREATENS 200% TARIFFS ON PHARMA IMPORTS

What Happened:
During a Cabinet meeting, President Trump announced plans to impose 200% tariffs on pharmaceutical imports “very soon” if drug companies fail to bring manufacturing back to the U.S. A grace period of 12 to 18 months will be given.

Market Reaction:

Biotech ETFs jumped:
SPDR S&P Biotech +1.4%,
iShares Biotech +0.9%,
ProShares Ultra Nasdaq Biotech +1.8%

Signals strong push toward reshoring U.S. drug production.

What It Means:

Pharma giants like J&J, Eli Lilly, and AbbVie may scale up local operations.

Supply chains might face disruption, impacting global drug costs.

Coins to Watch:

BTC – could benefit as global economic uncertainty rises.

ETH – DeFi innovation could gain traction amid centralized disruption.

---

FOLLOW ❤️

#CryptoNews #TrumpTariffs #PharmaCrisis #BinanceSquare #InsidePro

🚨🚨 #TrumpTariffs 🚨#pharmacrisis 🚨🚨

🔴 BREAKING: Trump to Announce Tariffs on Pharmaceuticals Soon 💊⚠
📌 Key Updates:
💰 Tariff Details: A 25% tax on imported pharmaceuticals from countries like Canada, Mexico, and China.
📈 Impact on Drug Prices: Industry warns higher medication costs and potential drug shortages in the U.S. 🚨
🏭 Supply Chain Risks: 72% of U.S. pharmaceutical ingredients come from abroad—tariffs could disrupt imports and delay production.
🌍 Global Economic Concerns: Countries like Ireland (a major pharma exporter) fear job losses and inflation 📉.
🚢 Industry Response: European drugmakers are rushing shipments to the U.S. before tariffs hit.

#Tarif #TariffsImpact

$BTC
$SOL
$ETH

🚨 #Trumptariffs 🚨#pharmacrisis 🚨
🔴 BREAKING: Trump to Announce Tariffs on Pharmaceuticals Soon 💊⚠
📌 Key Updates:
💰 Tariff Details: A 25% tax on imported pharmaceuticals from countries like Canada, Mexico, and China.
📈 Impact on Drug Prices: The industry warns higher medication costs and potential drug shortages in the U.S. 🚨
🏭 Supply Chain Risks: 72% of U.S. pharmaceutical ingredients come from abroad—tariffs could disrupt imports and delay production.
Global Economic Concerns: Countries like Ireland (a major pharma exporter) fear job losses and inflation 📉.
🚢 Industry Response: European drugmakers are rushing shipments to the U.S. before tariffs hit.
💭 What’s Next? Healthcare experts, economists, and global leaders are raising alarms 🚨 over possible trade wars and medical access issues

🚨🚨 #TrumpTariffs 🚨 #PharmaCrisis 🚨🚨

🔴 BREAKING: Trump Set to Announce Tariffs on Pharmaceuticals 💊⚠

📌 Key Updates:

💰 Tariff Details: A 25% tax on imported pharmaceuticals from Canada, Mexico, and China.

📈 Impact on Drug Prices: Experts warn of higher medication costs and potential drug shortages in the U.S. 🚨

🏭 Supply Chain Risks: 72% of U.S. pharmaceutical ingredients are imported—tariffs could disrupt supply chains and delay production.

🌍 Global Economic Concerns: Pharma-exporting countries like Ireland fear job losses and rising inflation 📉.

🚢 Industry Response: European drugmakers are rushing shipments to the U.S. before tariffs take effect.

💭 What’s Next? Healthcare experts, economists, and world leaders warn of trade wars and medical access issues 🚨.

🔗 Read more: CNN, Forbes, Reuters.

🚨🚨 #Trumptariffs 🚨#pharmacrisis 🚨🚨
🔴 BREAKING: Trump to Announce Tariffs on Pharmaceuticals Soon 💊⚠

📌 Key Updates:

💰 Tariff Details: A 25% tax on imported pharmaceuticals from countries like Canada, Mexico, and China.

📈 Impact on Drug Prices: Industry warns higher medication costs and potential drug shortages in the U.S. 🚨

🏭 Supply Chain Risks: 72% of U.S. pharmaceutical ingredients come from abroad—tariffs could disrupt imports and delay production.

🌍 Global Economic Concerns: Countries like Ireland (a major pharma exporter) fear job losses and inflation 📉.

🚢 Industry Response: European drugmakers are rushing shipments to the U.S. before tariffs hit.

💭 What’s Next? Healthcare experts, economists, and global leaders are raising alarms 🚨 over possible trade wars and medical access issues.

🔗 Read more: CNN, Forbes, Reuters.